Effect Of Hypertension (Htn) On Progression-Free Survival (Pfs) In Patients (Pts) Receiving Front-Line Bevacizumab (Bev) For Primary Advanced Ovarian Cancer (Oc) In The Noggo Single-Arm Otilia Study: A Post Hoc Analysis In 808 Pts.
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要